Serum leptin level may be a predictor of bone mineral loss in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2007; 30: Suppl. 51, 688s Year: 2007
Biomarkers to predict decreased bone mineral density in patients with chronic respiratory failure Source: Annual Congress 2009 - Prognosis and comorbidities in COPD Year: 2009
Bone turnover markers, bone mineral density and body composition in Tunisian patients with chronic obstructive pulmonary disease Source: Virtual Congress 2021 – Management of chronic cough and obstructive diseases Year: 2021
Comparative analysis of the oxyproline and calcium urine excretion data with bone tissue mineral density in patients with bronchial asthma treated by systemic and inhalation glucocorticoids Source: Eur Respir J 2006; 28: Suppl. 50, 324s Year: 2006
Correlation between vitamin D and bone mineral density in COPD Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010
The relationship between leptin and proinflammatory cytokines with bone mineral density in patients with sarcoidosis (pts) Source: Annual Congress 2012 - Diffuse parenchymal lung disease I Year: 2012
Severe asthma and high doses of corticosteroid adversely impact trabecular bone score more than bone mineral density Source: International Congress 2018 – Determinants and monitoring of asthma control Year: 2018
Bone mineral density and calciun metabolism in sarcoidosis at clinical onset Source: Eur Respir J 2004; 24: Suppl. 48, 714s Year: 2004
Serum leptin levels in patients with chronic airway diseases Source: Eur Respir J 2005; 26: Suppl. 49, 306s Year: 2005
Bone mineral density (BMD) measuring in patients suffering from pulmonary disease under glucocorticoid treatment - fashioned trend or necessity? Source: Eur Respir J 2005; 26: Suppl. 49, 526s Year: 2005
Bone mineral density changes in male patients with chronic obstructive pulmonary disease: clinical and biochemical variables in correlation with glucocorticoids use Source: Annual Congress 2009 - Healthcare and treatment of COPD Year: 2009
Elevated serum inflammatory markers in patients with stable COPD Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease Year: 2009
Plasma inflammatory markers associated with bone resorption in chronic obstructive pulmonary disease Source: Annual Congress 2008 - Novel targets in the molecular pathology of lung cancer and COPD Year: 2008
Influence of polymorphisms in the Col1a1, CTR and VDR genes on the risk of low bone density and osteoporotic fractures in patients with severe asthma receiving oral glucocorticoids Source: Eur Respir J 2006; 28: Suppl. 50, 323s Year: 2006
Bone mineral density in patients with chronic respiratory failure listed for transplantation Source: Annual Congress 2008 - Donor organs and complications after lung transplantation Year: 2008
Serum leptin, adponectin and its tissue expression in COPD patients with osteopenic syndrome Source: International Congress 2015 – COPD: notable points Year: 2015
Bone mineral density in patients with COPD depending on pulmonary function parameters Source: Annual Congress 2011 - COPD mechanisms Year: 2011
Serum interleukin-6 levels correlate with malnutrition in patients with acute exacerbation of COPD Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease Year: 2009
Serum magnesium levels in acute exacerbation of COPD Source: Annual Congress 2007 - Exacerbations of COPD Year: 2007
Loss of bone mineral density in patients with chronic obstructive pulmonary disease Source: Annual Congress 2007 - Primary care management of COPD Year: 2007